Description
Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023.
The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.
This report provides market sizing and estimates for COVID-19 tests with discussion of market impacts of COVID-19.
Some of the key topics and trends explored include:
- At-Home Testing
- Insurance Coverage
- Multiplex Testing
- Expiration of Public Health Emergency
- New Variants on the Horizon
- Immunoassay Testing
- Molecular Testing
Global Regional Analysis
The report’s global analysis features research, such as 2022-2027 sales estimates and forecasts, for regions and countries including:
- APAC
- Europe
- North America
- Rest of World
- Australia
- Austria
- Belgium
- Brazil
- Canada
- China
- Denmark
- France
- Germany
- India
- Italy
- Mexico
- Netherlands
- Japan
- Poland
- Romania
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Kingdom
- United States
Competitive Analysis
The report includes analysis and profiles of key companies competing in this industry, including a breakout of the top competitors in the COVID-19 testing market based on 2022 manufacturer revenues.
Companies profiled include:
- Abbott
- Access Bio, Inc
- Becton-Dickinson
- BioMérieux
- Bio-Rad
- Cue Health
- Danaher corporation
- Diasorin
- ELITechGroup
- Genedrive plc
- Hologic
- LumiraDx UK
- OraSure Technologies
- PerkinElmer, Inc
- Qiagen
- QuantuMDx
- QuidelOrtho
- Roche Diagnostic Corporation
- Seegene
- Siemens Healthineers
- Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
- Thermo Fisher Scientific
Scope and Methodology
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests. The base year for data was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top ten participants in the market. Regional breakdowns are surveyed for North America, Europe, Asia-Pacific and Rest of World. The forecasted market analysis through 2027 was largely based on demographic trends, new developments, trajectory of COVID-19 and its variants, innovative technology and global use.
Table of Contents
Chapter 1: Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
- Table 1-1: Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales by Segment, 2022-2027
- Figure 1-1: Global COVID-19 Market by Key Segment (Molecular, Immunoassay), 2020-2027
Key Issues and Trends Affecting the Market
Competitive Outlook
Conclusion Highlights
Chapter 2: Introduction
Overview
- Figure 2-1: Coronavirus (COVID-19) 7-Day Case Snapshot Global by Country
- Table 2-1: Coronavirus (COVID-19) Situation by WHO Region (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific)
- Figure 2-2: Coronavirus (COVID-19) Cumulative Cases and 7-Day Cases by WHO Region (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific)
- Figure 2-3: Country-Level COVID-19 Cumulative Cases, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
- Figure 2-4: Country-Level COVID-19 Cumulative Diagnostic Tests Administered, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
- Figure 2-5: New Cases vs. Total Cases for Select Countries with Uptick in Cases, by Country (Afghanistan, Austria, Czechia, Hong Kong, Indonesia, Japan, Mexico, Pakistan, Philippines, Poland, Russia, Saudi Arabia, South Korea, Vietnam), April 2023
Chapter 3: Issues and Trends
At-Home Testing
- Figure 3-1: At-Home COVID-19 Test Distribution of Sales, by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Quidel, Siemens Healthineers, Others)
Insurance Coverage
Multiplex Testing
EUAs and Public Health Emergency Expiration
New Variants On the Horizon
Chapter 4: COVID-19 Immunoassay Testing
Overview
Enzyme-linked Immunosorbent Assay (ELISA)
Mass Spectrometry
Rapid
Products
Antigen
- Table 4-1: Selected Antigen Immunoassay Tests for SARS-CoV-2
Antibody
- Table 4-2: Selected Antibody Immunoassay EUA Tests for COVID-19
Market Size and Growth
- Table 4-3: Global Immunoassay COVID-19 Testing Market, 2022-2027 $MN; CAGR 2022-2027
- Table 4-4: Estimated Global Immunoassay COVID-19 Testing Market Distribution by Segment (Antigen, Serology) and End User (Laboratory, Rapid/Near Patient), 2022, (%)
Competitive Market Share
- Figure 4-1: Immunoassay COVID-19 Vendor Market Share, by Vendor (Abbott, Beckman Coulter-Danaher, Becton Dickson, Diasorin, Fujirebio Diagnostics, PerkinElmer, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022 (%)
Chapter 5: COVID-19 Molecular Testing
Overview
Products
- Table 5-1: Selected Molecular EUA Tests for COVID-19
Market Size and Growth
- Table 5-2: Estimated Global Molecular COVID-19 Testing Market, 2022-2027 $MN; CAGR 2022-2027
- Table 5-3: Estimated Global Molecular COVID-19 Testing Market Distribution by End User (Laboratory, Rapid/Near Patient), 2022 (%)
Competitive Market Share
- Figure 5-1: Molecular COVID-19 Vendor Market Share, by Vendor (Abbott, bioMérieux, Cepheid-Danaher, Hologic, Orasure Technologies, PerkinElmer, Qiagen, QuidelOrtho, Roche, ThermoFisher, Others), 2022 (%)
Chapter 6: Total COVID-19 Testing Market Summary
Market Overview
- Table 6-1: Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales, by Segment, 2022-2027 ($MN)
- Figure 6-1: Global IVD Market (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2019-2022, ($MN)
- Figure 6-2: Global IVD Market, Distribution by Performance Segment (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2022 (%)
Market Segment by Test Type/Site
- Table 6-2: Global COVID-19 Testing by Test Site (Laboratory, Rapid/Near Patient) Sales by Segment, 2022-2027
- Figure 6-3: Global COVID-19 IVD Market by Test Site, 2020-2022 and Forecast Through 2027 ($MN)
Laboratory Based
- Table 6-3: Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
Point of Care
- Table 6-4: Global Rapid-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
- Figure 6-4: Global COVID-19 IVD Market by Test Method, 2020-2022 and Forecast Through 2027 ($MN)
Market by Region
- Figure 6-5: Estimated Global COVID-19 Testing Market by Region (APAC, Europe, North America, Rest of World), 2020-2022
- Figure 6-6: COVID-19 Testing Market by Country (Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Mexico, Netherlands, Japan, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States), Estimated 2022 ($M)
Competitive Analysis
- Figure 6-7: Top 10 COVID-19 Vendors and Global Market Share, by Vendor (Abbott, bioMérieux, Danaher, Hologic, PerkinElmer, Qiagen, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022
Chapter 7: Selected Market Participants
Abbott
- Table 7-1: Abbott Corporate Summary
Company Overview
COVID-19
Access Bio, Inc
- Table 7-2: Access Bio Corporate Summary
Company Overview
COVID-19
Becton-Dickinson
- Table 7-3: Becton-Dickinson Corporate Summary
Company Overview
COVID-19
bioMérieux
- Table 7-4: bioMérieux Corporate Summary
Company Overview
COVID-19
Bio-Rad
- Table 7-5: Corporate Summary
Company Overview
COVID-19
Cue Health
- Table 7-6: Cue Health Corporate Summary
Company Overview
COVID-19
Danaher Corporation
- Table 7-7: Danaher Corporate Summary
Company Overview
COVID-19
DiaSorin S.p.A.
- Table 7-8: DiaSorin Corporate Summary
Company Overview
COVID-19
ELITech Group S.A.S.
- Table 7-9: ELITech Group Corporate Summary
Company Overview
COVID-19
Genedrive plc
- Table 7-10: Genedrive Corporate Summary
Company Overview
COVID-19
Hologic, Inc
- Table 7-11: Hologic Corporate Summary
Company Overview
COVID-19
LumiraDx UK Limited
- Table 7-12: LumiraDx Corporate Summary
Company Overview
COVID-19
OraSure Technologies, Inc.
- Table 7-13: OraSure Technologies Summary
Company Overview
COVID-19
PerkinElmer, Inc
- Table 7-14: PerkinElmer Corporate Summary
Company Overview
COVID-19
QIAGEN N.V.
- Table 7-15: QIAGEN Corporate Summary
Company Overview
COVID-19
QuantuMDx Group, Ltd.
- Table 7-16: QuantuMDx Corporate Summary
Company Overview
COVID-19
QuidelOrtho Corporation
- Table 7-17: QuidelOrtho Corporate Summary
Company Overview
COVID-19
Roche Diagnostic Corporation
- Table 7-18: Roche Diagnostic Corporate Summary
Company Overview
COVID-19
Seegene, Inc
- Table 7-19: Seegene Corporate Summary
Company Overview
COVID-19
Siemens Healthineers GmbH
- Table 7-20: Siemens Healthineers Corporate Summary
Company Overview
COVID-19
Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
- Table 7-21: Snibe Corporate Summary
Company Overview
COVID-19
ThermoFisher Scientific
- Table 7-22: Thermo Fisher Scientific Corporate Summary
Company Overview
COVID-19
